Advertisement

Immunometabolism of Dendritic Cells and T Cells

  • Walter Gottlieb Land
Chapter

Abstract

In this short chapter, some aspects of immunometabolism of dendritic cells and T cells are briefly sketched. The dichotomous function of dendritic cells is associated with two different metabolic pathways. While resting dendritic cells use fatty acid oxidation to fuel the mitochondrial oxidative phosphorylation pathway, activated immunostimulatory dendritic cells typically switch to aerobic glycolysis, the Otto Warburg metabolism. In contrast to the metabolism of immunostimulatory dendritic cells, an inherently catabolic process, the Krebs cycle and fatty acid oxidation, plays a significant role in the development of tolerogenic dendritic cells.

Like dendritic cells, T cells must adapt to a vast array of environmental DAMPs as part of their regular development, during which they undergo a dramatic metabolic remodelling process as well. Research in this modern area of T cell biology has yielded striking findings on the roles of diverse metabolic pathways and metabolites, which have been found to regulate T cell signalling and influence their differentiation, function, and fate. For example, like immunostimulatory dendritic cells, immune response-promoting activated helper T cell subsets switch their metabolism to aerobic glycolysis, whereas regulatory T cells are less dependent on glycolysis but rely on oxidation phosphorylation pathway. Together, it has now become apparent that the dynamic regulation of metabolic pathways in both cell types drives our immune system to shape distinct T cell responses as required by any given stressful and/or injurious situation.

References

  1. 1.
    Pearce EL, Pearce EJ. Metabolic pathways in immune cell activation and quiescence. Immunity. 2013;38:633–43. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761313001581 CrossRefGoogle Scholar
  2. 2.
    Murray PJ, Rathmell J, Pearce E. SnapShot: immunometabolism. Cell Metab. 2015;22:190–190.e1. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1550413115002818 CrossRefGoogle Scholar
  3. 3.
    O’Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med. 2016;213:15–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26694970 CrossRefGoogle Scholar
  4. 4.
    O’Neill LAJ, Hardie DG. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493:346–55.  https://doi.org/10.1038/nature11862.CrossRefPubMedGoogle Scholar
  5. 5.
    Jha AK, Huang SC-C, Sergushichev A, Lampropoulou V, Ivanova Y, Loginicheva E, et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity. 2015;42:419–30. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761315000801 CrossRefGoogle Scholar
  6. 6.
    Tannahill GM, Curtis AM, Adamik J, EM P-MD, AF MG, G G, et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23535595 CrossRefGoogle Scholar
  7. 7.
    Buck MD, O’Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med. 2015;212:1345–60. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26261266 CrossRefGoogle Scholar
  8. 8.
    Warburg O, Gawehn K, Geissler AW. Metabolism of leukocytes. Z Naturforsch B. 1958;13B:515–6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/13593654 CrossRefGoogle Scholar
  9. 9.
    Pearce EJ, Everts B. Dendritic cell metabolism. Nat Rev Immunol. 2015;15:18–29. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25534620 CrossRefGoogle Scholar
  10. 10.
    McGettrick AF, O’Neill LAJ. How metabolism generates signals during innate immunity and inflammation. J Biol Chem. 2013;288:22893–8.  https://doi.org/10.1074/jbc.R113.486464.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Cameron AM, Lawless SJ, Pearce EJ. Metabolism and acetylation in innate immune cell function and fate. Semin Immunol. 2016;28:408–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28340958 CrossRefGoogle Scholar
  12. 12.
    Saas P, Varin A, Perruche S, Ceroi A. Recent insights into the implications of metabolism in plasmacytoid dendritic cell innate functions: potential ways to control these functions. Version 2. F1000Res. 2017;6:456. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28580131 CrossRefGoogle Scholar
  13. 13.
    Krawczyk CM, Holowka T, Sun J, Blagih J, Amiel E, DeBerardinis RJ, et al. Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood. 2010;115:4742–9.  https://doi.org/10.1182/blood-2009-10-249540.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG, et al. Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol. 2008;180:4697–705. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18354193 CrossRefGoogle Scholar
  15. 15.
    Everts B, Amiel E, Huang SC-C, Smith AM, Chang C-H, Lam WY, et al. TLR-driven early glycolytic reprogramming via the kinases TBK1-IKKɛ supports the anabolic demands of dendritic cell activation. Nat Immunol. 2014;15:323–32.  https://doi.org/10.1038/ni.2833.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Everts B, Amiel E, van der Windt GJW, Freitas TC, Chott R, Yarasheski KE, et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012;120:1422–31.  https://doi.org/10.1182/blood-2012-03-419747.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Malinarich F, Duan K, Hamid RA, Bijin A, Lin WX, Poidinger M, et al. High mitochondrial respiration and glycolytic capacity represent a metabolic phenotype of human tolerogenic dendritic cells. J Immunol. 2015;194:5174–86.  https://doi.org/10.4049/jimmunol.1303316.CrossRefPubMedGoogle Scholar
  18. 18.
    Svajger U, Obermajer N, Jeras M. Dendritic cells treated with resveratrol during differentiation from monocytes gain substantial tolerogenic properties upon activation. Immunology. 2010;129:525–35.  https://doi.org/10.1111/j.1365-2567.2009.03205.x.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ferreira GB, Vanherwegen A-S, Eelen G, Gutiérrez ACF, Van Lommel L, Marchal K, et al. Vitamin D3 induces tolerance in human dendritic cells by activation of intracellular metabolic pathways. Cell Rep. 2015;10:711–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2211124715000261 CrossRefGoogle Scholar
  20. 20.
    Cubillos-Ruiz JR, Silberman PC, Rutkowski MR, Chopra S, Perales-Puchalt A, Song M, et al. ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis. Cell. 2015;161:1527–38. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0092867415005759 CrossRefGoogle Scholar
  21. 21.
    Pearce EL, Poffenberger MC, Chang C-H, Jones RG. Fueling immunity: insights into metabolism and lymphocyte function. Science. 2013;342:1242454.  https://doi.org/10.1126/science.1242454.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    van der Windt GJW, Pearce EL. Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev. 2012;249:27–42.  https://doi.org/10.1111/j.1600-065X.2012.01150.x.CrossRefPubMedPubMedCentralGoogle Scholar
  23. 23.
    Chao T, Wang H, Ho P-C. Mitochondrial control and guidance of cellular activities of T cells. Front Immunol. 2017;8:473. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28484465 CrossRefGoogle Scholar
  24. 24.
    Buck MD, Sowell RT, Kaech SM, Pearce EL. Metabolic instruction of immunity. Cell. 2017;169:570–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28475890 CrossRefGoogle Scholar
  25. 25.
    Michalek RD, Gerriets VA, Jacobs SR, Macintyre AN, MacIver NJ, Mason EF, et al. Cutting edge: distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J Immunol. 2011;186:3299–303.  https://doi.org/10.4049/jimmunol.1003613.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science. 2016;354:481–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27708054 CrossRefGoogle Scholar
  27. 27.
    Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR, et al. HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med. 2011;208:1367–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21708926 CrossRefGoogle Scholar
  28. 28.
    Araujo L, Khim P, Mkhikian H, Mortales C-L, Demetriou M. Glycolysis and glutaminolysis cooperatively control T cell function by limiting metabolite supply to N-glycosylation. elife. 2017;6. Available from: http://www.ncbi.nlm.nih.gov/pubmed/28059703
  29. 29.
    Zeng H, Cohen S, Guy C, Shrestha S, Neale G, Brown SA, et al. mTORC1 and mTORC2 kinase signaling and glucose metabolism drive follicular helper T cell differentiation. Immunity. 2016;45:540–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27637146 CrossRefGoogle Scholar
  30. 30.
    Kopf H, de la Rosa GM, Howard OMZ, Chen X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+ T regulatory cells. Int Immunopharmacol. 2007;7:1819–24. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1567576907002809 CrossRefGoogle Scholar
  31. 31.
    Delgoffe GM, Kole TP, Zheng Y, Zarek PE, Matthews KL, Xiao B, et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity. 2009;30:832–44. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1074761309002374 CrossRefGoogle Scholar
  32. 32.
    Angelin A, Gil-de-Gómez L, Dahiya S, Jiao J, Guo L, Levine MH, et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 2017;25:1282–1293.e7. Available from: http://linkinghub.elsevier.com/retrieve/pii/S1550413116306519 CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of StrasbourgMolecular ImmunoRheumatology, Laboratory of Excellence TransplantexStrasbourgFrance

Personalised recommendations